Giovanni Fucà (Giovanni Fuca)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 31

Top Venues

Journal for immunotherapy of cancer

Scientific reports

The oncologist

International journal of cancer

University of Palermo (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Palermo

Italy

PHD

Publications

Giovanni Fucà, Ilaria Sabatucci, Mariachiara Paderno, Domenica Lorusso
The clinical landscape of antibody-drug conjugates in endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Emma Zattarin, Daniele Presti, Luigi Mariani, Caterina Sposetti, Rita Leporati, Alice Menichetti, Chiara Corti, Chiara Benvenuti, Giovanni Fucà, Riccardo Lobefaro, Francesca Ligorio, Leonardo Provenzano, Andrea Vingiani, Marta Del Vecchio, Gaia Griguolo, Marianna Sirico, Ottavia Bernocchi, Antonio Marra, Paola Zagami, Elisa Agostinetto, Flavia Jacobs, Pierluigi di Mauro, Andrea Esposito, Carlo Alberto Giorgi, Luca Lalli, Laura Boldrini, Pier Paolo Berton Giacchetti, Ambra Carnevale Schianca, Valentina Guarneri, Rebecca Pedersini, Agnese Losurdo, Alberto Zambelli, Daniele Generali, Carmen Criscitiello, Curigliano Giuseppe, Giancarlo Pruneri, Filippo de Braud, Maria Vittoria Dieci, Claudio Vernieri
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors. NPJ breast cancer 9 (1) (2023)
Francesca Ligorio, Riccardo Lobefaro, Giovanni Fucà, Leonardo Provenzano, Lucrezia Zanenga, Vincenzo Nasca, Caterina Sposetti, Giulia Salvadori, Angela Ficchì, Andrea Franza, Antonia Martinetti, Elisa Sottotetti, Barbara Formisano, Catherine Depretto, Gianfranco Scaperrotta, Antonino Belfiore, Andrea Vingiani, Cristina Ferraris, Giancarlo Pruneri, Filippo de Braud, Claudio Vernieri
Adding fasting-mimicking diet to first-line carboplatin-based chemotherapy is associated with better overall survival in advanced triple-negative breast cancer patients: A subanalysis of the NCT03340935 trial. International journal of cancer (2023)
Giovanni Fucà, Alessandra Raimondi, Michele Prisciandaro, Sara Lonardi, Chiara Cremolini, Margherita Ratti, Matteo Clavarezza, Roberto Murialdo, Andrea Sartore-Bianchi, Valeria Smiroldo, Rosa Berenato, Patrizia Racca, Francesca Bergamo, Salvatore Corallo, Maria Di Bartolomeo, Filippo G De Braud, Federica Morano, Filippo Pietrantonio
Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study. The oncologist 27 (1) (2022)
Loïc Reppel, Ourania Tsahouridis, Jason Akulian, Ian J Davis, Hong Lee, Giovanni Fucà, Jared Weiss, Gianpietro Dotti, Chad V Pecot, Barbara Savoldo
Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer. Journal for immunotherapy of cancer 10 (1) (2022)
Giovanni Fucà, Romain Cohen, Sara Lonardi, Kohei Shitara, Maria Elena Elez, Marwan Fakih, Joseph Chao, Samuel J Klempner, Matthew Emmett, Priya Jayachandran, Francesca Bergamo, Marc Díez García, Giacomo Mazzoli, Leonardo Provenzano, Raphael Colle, Magali Svrcek, Margherita Ambrosini, Giovanni Randon, Aakash Tushar Shah, Massimiliano Salati, Elisabetta Fenocchio, Lisa Salvatore, Keigo Chida, Akihito Kawazoe, Veronica Conca, Giuseppe Curigliano, Francesca Corti, Chiara Cremolini, Michael Overman, Thierry André, Filippo Pietrantonio
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers. Journal for immunotherapy of cancer 10 (2) (2022)
Filippo Pietrantonio, Sara Lonardi, Francesca Corti, Gabriele Infante, Maria Elena Elez, Marwan Fakih, Priya Jayachandran, Aakash Tushar Shah, Massimiliano Salati, Elisabetta Fenocchio, Lisa Salvatore, Giuseppe Curigliano, Chiara Cremolini, Margherita Ambrosini, Javier Ros, Rossana Intini, Floriana Nappo, Silvia Damian, Federica Morano, Giovanni Fucà, Michael Overman, Rosalba Miceli
Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors. Journal for immunotherapy of cancer 9 (8) (2022)
Giovanni Fucà, Margherita Ambrosini, Luca Agnelli, Silvia Brich, Francesco Sgambelluri, Roberta Mortarini, Serenella M Pupa, Michele Magni, Liliana Devizzi, Paola Matteucci, Antonello Cabras, Roberta Zappasodi, Francesca De Santis, Andrea Anichini, Filippo De Braud, Alessandro M Gianni, Massimo Di Nicola
Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells. Journal for immunotherapy of cancer 9 (6) (2022)
Giovanni Fucà, Francesca Corti, Filippo Pietrantonio
Author response to Colle et al. Journal for immunotherapy of cancer 9 (6) (2021)
Francesco Pantano, Salvatore Corallo, Sara Lonardi, Giovanni Fucà, Adele Busico, Alberto Giovanni Leone, Francesca Corti, Carlotta Antoniotti, Letizia Procaccio, Valeria Smiroldo, Margherita Ratti, Roberto Murialdo, Patrizia Racca, Filippo Pagani, Giovanni Randon, Antonia Martinetti, Elisa Sottotetti, Michele Prisciandaro, Margherita Ambrosini, Alessandra Raimondi, Federica Morano, Filippo Pietrantonio
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study. British journal of cancer (2021)
Giovanni Fucà, Francesca Corti, Margherita Ambrosini, Rossana Intini, Massimiliano Salati, Elisabetta Fenocchio, Paolo Manca, Chiara Manai, Francesca Daniel, Alessandra Raimondi, Federica Morano, Salvatore Corallo, Michele Prisciandaro, Andrea Spallanzani, Virginia Quarà, Carmen Belli, Marta Vaiani, Giuseppe Curigliano, Chiara Cremolini, Filippo De Braud, Maria Di Bartolomeo, Vittorina Zagonel, Sara Lonardi, Filippo Pietrantonio
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors. Journal for immunotherapy of cancer 9 (4) (2021)
Chiara Fabbroni, Giovanni Fucà, Francesca Ligorio, Elena Fumagalli, Marta Barisella, Paola Collini, Carlo Morosi, Alessandro Gronchi, Angelo Paolo Dei Tos, Paolo Giovanni Casali, Roberta Sanfilippo
Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin. Cancers 13 (6) (2021)
Francesca Ligorio, Giovanni Fucà, Emma Zattarin, Riccardo Lobefaro, Luca Zambelli, Rita Leporati, Carmen Rea, Gabriella Mariani, Giulia V Bianchi, Giuseppe Capri, Filippo de Braud, Claudio Vernieri
The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Breast Cancer Treated with First-Line Taxane-Trastuzumab-Pertuzumab. Cancers 13 (8) (2021)
Filippo Pietrantonio, Giovanni Fucà, Daniele Rossini, Hans-Joachim Schmoll, Johanna C Bendell, Federica Morano, Carlotta Antoniotti, Salvatore Corallo, Beatrice Borelli, Alessandra Raimondi, Federica Marmorino, Monica Niger, Alessandra Boccaccino, Gianluca Masi, Sara Lonardi, Luca Boni, Filippo de Braud, Maria Di Bartolomeo, Alfredo Falcone, Chiara Cremolini
FOLFOXIRI-Bevacizumab or FOLFOX-Panitumumab in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Propensity Score-Based Analysis. The oncologist 26 (4) (2021)
Francesco Mainini, Francesca De Santis, Giovanni Fucà, Massimo Di Nicola, Licia Rivoltini, Michael R Eccles
Nanobiotechnology and Immunotherapy: Two Powerful and Cooperative Allies against Cancer. Cancers 13 (15) (2021)
Claudio Vernieri, Giovanni Fucà, Francesca Ligorio, Veronica Huber, Andrea Vingiani, Fabio Iannelli, Alessandra Raimondi, Darawan Rinchai, Gianmaria Frigè, Antonino Belfiore, Luca Lalli, Claudia Chiodoni, Valeria Cancila, Federica Zanardi, Arta Ajazi, Salvatore Cortellino, Viviana Vallacchi, Paola Squarcina, Agata Cova, Samantha Pesce, Paola Frati, Raghvendra Mall, Paola Antonia Corsetto, Angela Maria Rizzo, Cristina Ferraris, Secondo Folli, Marina Chiara Garassino, Giuseppe Capri, Giulia Bianchi, Mario Paolo Colombo, Saverio Minucci, Marco Foiani, Valter Daniel Longo, Giovanni Apolone, Valter Torri, Giancarlo Pruneri, Davide Bedognetti, Licia Rivoltini, Filippo de Braud
Fasting-mimicking diet is safe and reshapes metabolism and antitumor immunity in cancer patients. Cancer discovery (2021)
Giovanni Fucà, Teresa Beninato, Marta Bini, Laura Mazzeo, Lorenza Di Guardo, Carolina Cimminiello, Giovanni Randon, Giulia Apollonio, Ilaria Bisogno, Marta Del Vecchio, Claudia Lauria Pantano, Massimo Di Nicola, Filippo de Braud, Michele Del Vecchio
The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy. Targeted oncology 16 (4) (2021)
Roberta Sanfilippo, Chiara Fabbroni, Giovanni Fucà, Elena Fumagalli, Carlo Morosi, Marta Sbaraglia, Alessandro Gronchi, Paola Collini, Angelo Paolo Dei Tos, Paolo G Casali
Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (20) (2020)
Chiara Costanza Volpi, Filippo Pietrantonio, Annunziata Gloghini, Giovanni Fucà, Silvia Giordano, Simona Corso, Giancarlo Pruneri, Maria Antista, Chiara Cremolini, Elena Fasano, Serena Saggio, Simona Faraci, Maria Di Bartolomeo, Filippo de Braud, Massimo Di Nicola, Elda Tagliabue, Serenella Maria Pupa, Lorenzo Castagnoli
Author Correction: The landscape of d16HER2 splice variant expression across HER2-positive cancers. Scientific reports 10 (1) (2020)
Andreas Schlicker, Architha Ellappalayam, Ines J Beumer, Mireille H J Snel, Lorenza Mittempergher, Begona Diosdado, Christa Dreezen, Sun Tian, Ramon Salazar, Fotios Loupakis, Filippo Pietrantonio, Cristina Santos Vivas, Maria Mercedes Martinez-Villacampa, Alberto Villanueva, Xavier Sanjuán, Marta Schirripa, Matteo Fassan, Antonia Martinetti, Giovanni Fucà, Sara Lonardi, Ulrich Keilholz, Annuska M Glas, René Bernards, Loredana Vecchione
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis. International journal of cancer 147 (8) (2020)
Filippo Pietrantonio, Riccardo Lobefaro, Maria Antista, Sara Lonardi, Alessandra Raimondi, Federica Morano, Stefania Mosconi, Lorenza Rimassa, Sabina Murgioni, Andrea Sartore-Bianchi, Gianluca Tomasello, Raffaella Longarini, Gabriella Farina, Fausto Petrelli, Stefania Gori, Giovanni Randon, Salvatore Corallo, Filippo Pagani, Vincenzo Guarini, Federica Palermo, Antonia Martinetti, Marco Macagno, Ludovic Barault, Federica Perrone, Elena Tamborini, Massimo Milione, Federica Di Nicolantonio, Massimo Di Maio, Giovanni Fucà, Maria Di Bartolomeo, Filippo de Braud
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (5) (2019)
Giovanni Fucà, Giulia Galli, Marta Poggi, Giuseppe Lo Russo, Claudia Proto, Martina Imbimbo, Milena Vitali, Monica Ganzinelli, Claudia Lanti, Giuliano Molino, Fabiano Stangoni, Nicoletta Zilembo, Filippo de Braud, Marina Chiara Garassino, Diego Signorelli
Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy. Targeted oncology 13 (6) (2019)
Maria Di Bartolomeo, Federica Morano, Alessandra Raimondi, Rosalba Miceli, Salvatore Corallo, Elena Tamborini, Federica Perrone, Maria Antista, Monica Niger, Alessandro Pellegrinelli, Giovanni Randon, Filippo Pagani, Antonia Martinetti, Giovanni Fucà, Filippo Pietrantonio, null null
Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial. The oncologist 25 (3) (2019)
Claudio Vernieri, Sara Pusceddu, Giovanni Fucà, Pietro Indelicato, Giovanni Centonze, Lorenzo Castagnoli, Elisa Ferrari, Arta Ajazi, Serenella Maria Pupa, Stefano Casola, Marco Foiani, Vincenzo Mazzaferro, Giancarlo Pruneri, Massimo Milione, Filippo de Braud
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs). International journal of cancer 144 (7) (2019)
Chiara Costanza Volpi, Filippo Pietrantonio, Annunziata Gloghini, Giovanni Fucà, Silvia Giordano, Simona Corso, Giancarlo Pruneri, Maria Antista, Chiara Cremolini, Elena Fasano, Serena Saggio, Simona Faraci, Maria Di Bartolomeo, Filippo de Braud, Massimo Di Nicola, Elda Tagliabue, Serenella Maria Pupa, Lorenzo Castagnoli
The landscape of d16HER2 splice variant expression across HER2-positive cancers. Scientific reports 9 (1) (2019)
Giovanni Randon, Giovanni Fucà, Daniele Rossini, Alessandra Raimondi, Filippo Pagani, Federica Perrone, Elena Tamborini, Adele Busico, Giorgia Peverelli, Federica Morano, Monica Niger, Maria Antista, Salvatore Corallo, Serena Saggio, Beatrice Borelli, Gemma Zucchelli, Massimo Milione, Giancarlo Pruneri, Maria Di Bartolomeo, Alfredo Falcone, Filippo de Braud, Chiara Cremolini, Filippo Pietrantonio
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer. Scientific reports 9 (1) (2019)
Federico Nichetti, Felicia Stefania Falvella, Rosalba Miceli, Stefania Cheli, Raffaella Gaetano, Giovanni Fucà, Gabriele Infante, Antonia Martinetti, Carlotta Antoniotti, Alfredo Falcone, Maria Di Bartolomeo, Chiara Cremolini, Filippo de Braud, Filippo Pietrantonio
Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? The pharmacogenomics journal 19 (5) (2019)
Chiara Cremolini, Matteo Benelli, Elisa Fontana, Filippo Pagani, Daniele Rossini, Giovanni Fucà, Adele Busico, Elena Conca, Samantha Di Donato, Fotios Loupakis, Marta Schirripa, Sara Lonardi, Beatrice Borelli, Elena Ongaro, Katherine Eason, Federica Morano, Mariaelena Casagrande, Matteo Fassan, Anguraj Sadanandam, Filippo de Braud, Alfredo Falcone, Filippo Pietrantonio
Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept study. ESMO open 4 (2) (2019)
Giovanni Fucà, Luigi Mariani, Salvatore Lo Vullo, Giulia Galli, Rossana Berardi, Massimo Di Nicola, Claudio Vernieri, Daniele Morelli, Katia Dotti, Ilaria Fiordoliva, Silvia Rinaldi, Cecilia Gavazzi, Filippo Pietrantonio, Marco Platania, Filippo de Braud
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study. Scientific reports 9 (1) (2019)
Maria Di Bartolomeo, Federica Morano, Alessandra Raimondi, Rosalba Miceli, Salvatore Corallo, Elena Tamborini, Federica Perrone, Maria Antista, Monica Niger, Alessandro Pellegrinelli, Giovanni Randon, Filippo Pagani, Antonia Martinetti, Giovanni Fucà, Filippo Pietrantonio, null null
Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial. The oncologist (2019)
Giovanni Fucà, Giulia Galli, Marta Poggi, Giuseppe Lo Russo, Claudia Proto, Martina Imbimbo, Roberto Ferrara, Nicoletta Zilembo, Monica Ganzinelli, Antonio Sica, Valter Torri, Mario Paolo Colombo, Claudio Vernieri, Andrea Balsari, Filippo de Braud, Marina Chiara Garassino, Diego Signorelli
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors. ESMO open 4 (1) (2019)

Giovanni Fucà.css-eqlu8i{font-size:small;padding-left:4px;} (Giovanni Fuca)

Publication Activity (10 Years)

Top Topics

Top Venues

Giovanni Fucà (Giovanni Fuca)